COVID-19 Updates
Latest News
Today’s top news highlights: Remdesivir data dive, FDA approves contraceptive gel
FDA approves the first contraceptive gel and researchers published full results from a remdesivir trial.
Commentary
Is HIPAA critical?
Latest News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
News
Remdesivir shortens COVID-19 time to recovery in published study
The NIAID reported initial promising results from the study earlier this month, which prompted the FDA to issue an emergency use authorization for...
Commentary
Armchair epidemiology
This armchair epidemiologist suspects that, when we are talking about an outside space, the 6-foot guideline for small groups is overly...
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
Latest News
Today’s top news highlights: ACE inhibitors in COVID patients, fewer AMI admissions, and more
Older patients with COVID-19 had a lower risk of developing severe illness if they were taking ACE inhibitors in a new study.
Commentary
COVID-19 and Mental Health Awareness Month
As a community, we must be prepared to meet the escalating needs of our population, said Dr. Eva Ritvo.
Feature
ACE inhibitors and severe COVID-19: Protective in older patients?
A randomized trial is planned after a study showed that fewer older hypertensive patients taking ACE inhibitors were hospitalized with COVID-19....
From the Journals
As visits for AMI drop during pandemic, deaths rise
Latest News
Today’s top news highlights: COVID-19 vaccine hurdles, new options in prostate cancer
Vaccine-induced neutralizing antibodies may not be enough to provide sustained protection agains the coronavirus.